Literature DB >> 28770377

1,6-O,O-Diacetylbritannilactone Inhibits Eotaxin-1 and ALOX15 Expression Through Inactivation of STAT6 in A549 Cells.

Xi Chen1,2, Ning Ji1, Nan Qin3, Sheng-An Tang1, Ran Wang1, Yuling Qiu1, Hongquan Duan1,3, Dexin Kong1,3, Meihua Jin4.   

Abstract

1,6-O,O-Diacetylbritannilactone (OODBL), a plant sesquiterpene lactone, was previously reported to show multiple pharmacological effects such as anti-cancer and anti-inflammatory activities. In this study, we investigated the anti-inflammatory effect of OODBL on interleukin (IL)-4-induced signal transducer and activator of transcription 6 (STAT6) signaling pathway in human lung A549 cells. We found that OODBL dramatically inhibited IL-4-induced messenger RNA (mRNA) expression of eotaxin-1 and arachidonate 15-lipoxygenase-1 (ALOX15) in a dose-dependent manner. To clarify the action mechanism of OODBL, we examined the effect of OODBL on activation of STAT6. OODBL decreased both STAT6 phosphorylation and reporter gene activity. Furthermore, OODBL suppressed phosphorylation of Janus Kinase 3 (JAK3) without affecting JAK1. Taken together, OODBL abolished IL-4-induced eotaxin-1 and ALOX15 mRNA expressions by repressing the activation of STAT6 and JAK3. These results suggest that OODBL has a potential therapeutic efficacy on inflammatory diseases especially allergic airway disease as a lead compound.

Entities:  

Keywords:  1,6-O,O-diacetylbritannilactone; ALOX-15; JAK3; STAT6; eotaxin-1

Mesh:

Substances:

Year:  2017        PMID: 28770377     DOI: 10.1007/s10753-017-0637-y

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  3 in total

Review 1.  Emerging cellular functions of the lipid metabolizing enzyme 15-Lipoxygenase-1.

Authors:  Melis Çolakoğlu; Sinem Tunçer; Sreeparna Banerjee
Journal:  Cell Prolif       Date:  2018-07-30       Impact factor: 6.831

2.  1, 6-O, O-Diacetylbritannilactone from Inula britannica Induces Anti-Tumor Effect on Oral Squamous Cell Carcinoma via miR-1247-3p/LXRα/ABCA1 Signaling.

Authors:  Shaohua Zheng; Lihua Li; Na Li; Yi Du; Nan Zhang
Journal:  Onco Targets Ther       Date:  2020-10-29       Impact factor: 4.147

Review 3.  Targeting ferroptosis as a vulnerability in pulmonary diseases.

Authors:  Li Yang; Li-Mian Cao; Xiao-Ju Zhang; Bo Chu
Journal:  Cell Death Dis       Date:  2022-07-26       Impact factor: 9.685

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.